6/1/13 Phase 2 Study Results for Tivantinib in Combination with Cetuximab and Irinotecan for Colorectal Cancer Presented at ASCO 2013
5/30/13 ArQule, Inc. to Present at Jefferies 2013 Global Healthcare Conference
